Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214129) titled 'Safety and Efficacy of Nebulized Nitroglycerin in Pulmonary Arterial Hypertension' on Oct. 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Mansoura University

Condition: Pulmonary Arterial Hypertension

Intervention: Drug: Nebulized nitroglycerin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 1, 2022

Target Sample Size: 20

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07214129

Published by HT Digital ...